Archives: 5/2008

43634md4 MediDome Drug Injector Is Designed with Patient in Mind
Christopher Holden, a 21 year old student, thinks he has the answer to an old medical combo of needle and syringe. His little design project called MediDome has been getting accolades from RSA (Royal Society for the Encouragements of Arts, Manufactures and Commerce), and is now being patented by his school, Northumbria University in Newcastle.
43634md2 MediDome Drug Injector Is Designed with Patient in MindRSA explains how the device works:

Christopher’s project, ‘MediDome’, redesigns the needle and syringe. It aims to eliminate needlestick injuries and the fear of needles and injections, simplify the process and speed up patient treatment. The product’s aesthetics show a softer, friendlier and less threatening form, and MediDome has a unique tester to ensure that a vein has not been ruptured during intramuscular or subcutaneous injection. A sterile cover is removed to expose adhesive wings that stick the MediDome to the required area for injection. The person administering the injection removes the blister cap and presses down on the top of MediDome until a little resistance is felt. A bubble on one of the wings is checked for blood – if it fills up the injection is halted. If all is well, they then give a small firm press until a click is heard, then softly compress and hold the dome. On release, MediDome returns to its original shape (but cannot be compressed again), is removed from the arm and disposed of for incineration. It is a fail safe single use design – once used it can never be used again, so syringes cannot be shared, and viruses such as HIV or blood born diseases cannot be passed on. It is made from a soft flexible plastic, pre-filled with a measured drug dose (eliminating the need for priming), all manufactured in one factory as one product, which means lower cost production. MediDome uses a universal colour coding drug system – the ring is a different colour depending on which drug is in the pre-filled reservoir. Minimal packaging reduces the product’s carbon footprint, and a large label area contains all necessary information, such as drug name and dosage. The peel off adhesive cover also acts as a tamper alarm – it changes colour if the product has been ruptured or tampered with. A companion product, the Absorption MediDome, works in the same way for drugs such as painkillers and certain antibiotics but without the needle. During his research, Christopher consulted the Head of Clinical Governance and Risk, the Chief of Electronics and Medical Engineering, and the Head of Health and Safety Adviser (the latter also a former nurse) at the Newcastle upon Tyne Hospitals NHS Foundation Trust. MediDome would also bring benefits when used in military and natural disaster situations, and mass immunisation in developing countries.

43634md3 MediDome Drug Injector Is Designed with Patient in Mind
Project page: MediDome…
Press release: Novel replacement for conventional needle and syringe…

2352vir Scientists Create Self Assembling Artificial Virus with NanotentaclesReporting in the latest Angewandte Chemie International Edition , a group of scientists from the Yonsei University in Seoul, Korea created an artificial virus equipped with hydrophobic tentacles, and loaded with a chemical load which can be delivered intracellularly, or even into the nucleus:

Viruses are true experts at importing genetic material into the cells of an infected organism. This trait is now being exploited for gene therapy, in which genes are brought into the cells of a patient to treat genetic diseases or genetic defects. Korean researchers have now made an artificial virus. As described in the journal Angewandte Chemie, they have been able to use it to transport both genes and drugs into the interior of cancer cells.
Natural viruses are extremely effective at transporting genes into cells for gene therapy; their disadvantage is that they can initiate an immune response or cause cancer. Artificial viruses do not have these side effects, but are not especially effective because their size and shape are very difficult to control—but crucial to their effectiveness. A research team headed by Myongsoo Lee has now developed a new strategy that allows the artificial viruses to maintain a defined form and size.
The researchers started with a ribbonlike protein structure (β-sheet) as their template. The protein ribbons organized themselves into a defined threadlike double layer that sets the shape and size. Coupled to the outside are “protein arms” that bind short RNA helices and embed them. If this RNA is made complementary to a specific gene sequence, it can very specifically block the reading of this gene. Known as small interfering RNAs (siRNA), these sequences represent a promising approach to gene therapy.
Glucose building blocks on the surfaces of the artificial viruses should improve binding of the artificial virus to the glucose transporters on the surfaces of the target cells. These transporters are present in nearly all mammalian cells. Tumor cells have an especially large number of these transporters.
Trials with a line of human cancer cells demonstrated that the artificial viruses very effectively transport an siRNA and block the target gene.
In addition, the researchers were able to attach hydrophobic (water repellant) molecules—for demonstration purposes a dye—to the artificial viruses. The dye was transported into the nuclei of tumor cells. This result is particularly interesting because the nucleus is the target for many important antitumor agents.

Press release: Self-Assembled Viruses…
Abstract: Filamentous Artificial Virus from a Self-Assembled Discrete Nanoribbon
(hat tip: io9)

6876dig Digital Clubbing ExplainedDigital clubbing, a classic medical sign of chronic hypoxemia, first described by Hippocrates in patients with empyema, has now been explained on the molecular level. A group of clinicians at Leeds University realized that a genetic mutation in one of the genes responsible for the breakdown of PGE2 prostaglandin results in increased clubbing.
And the rest is history:

Prof Bonthron, Dr Chris Bennett of the Yorkshire Regional Genetics Service and their colleagues studied a group of patients suffering from inherited primary hypertrophic osteoarthropathy (PHO), a genetic disorder in which the finger clubbing is accompanied by painful joint enlargement and a thickening of the bone.
Their findings implicated a fatty compound called PGE2, which is produced naturally by the body to mediate the effects of internal inflammation. Crucially, once it has done its work, PGE2 is broken down by an enzyme 15-HPGD, produced in the lungs. The patients followed by the Leeds study were found to have a genetic mutation which prevented the production of 15-HPGD, resulting in up to ten times as much of the PGE2 in their systems.
"If you don’t have this enzyme the PGE2 isn’t broken down normally and simply builds up," said Bonthron, whose findings are published online this week in Nature Genetics.
In lung cancer patients, it is most likely overproduction of PGE2 by the tumour that causes the clubbing. In congenital heart disease, blood bypasses the lungs, where PGE2 is normally broken down by 15-HPGD.
The researchers have suggested that a straightforward urine test for levels of PGE2 may be a useful first step in the diagnosis of individuals with unexplained clubbing, and to understanding whether it is the symptom of something far more serious. The results also suggest that existing drugs such as aspirin, which are already used to prevent PGE2 production, may be effective in reducing the painful symptoms of finger clubbing.
It has taken 2,000 years to make the connection, but Bonthron adds: "Actually, when you look back, it’s rather obvious. When we found this gene, everything else fell neatly into place – it was like a smack on the forehead."

Press release: Leeds medics solve an ancient riddle — and offer new tool for diagnosis…
Abstract: Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy Nature Genetics 40, 789 – 793 (2008)

  • How Health Reform Could Hurt Military Recruitment … [WSJ]
  • Liver Damage: Scarce Organs at UCLA Went to Japanese Criminals … [WSJ]
  • Researchers Clear up Alzheimer’s Plaques in Mice… [Yale]
  • Google Health — A view from the Inside… [THCB]
  • 23andme presents its consumer strategy… [ZDNet Healthcare]
  • Patenting and licensing in genetic testing… [European Journal of Human Genetics]
  • Microsoft increases Be Well prize fund by 50%… [ZDNet Healthcare]
  • France’s research agency splits up… [Nature]
  • New Bullseye for Cancer Treatment: A Gene Called KRAS … [WSJ]
  • Scientists Identify a Brain Mechanism Underlying Persistent Cocaine Craving… [NIH]
  • NIH Researchers Find That Rett Syndrome Gene is Full of Surprises… [NIH]
  • FDA Proposes New Rule to Provide Updated Information on the Use of Prescription Drugs and Biological Products During Pregnancy and Breast-feeding … [FDA]
  • Protein plays key role in transmitting deadly malaria parasite… [University of South Florida]
  • Timer genes control brain size… [Medical research Council UK]
  • Magnetic nanoparticles: suitable for cancer therapy?… [Physikalisch-Technische Bundesanstalt ]
  • Obama’s Health Is Great, but What About Those Cigarettes? … [WSJ]
  • Status Panicus… [ER Stories]
  • 42535wi1 The Official Website of Nanobot Nanosoccer
    The National Institute of Standards and Technology (NIST) has released more details about the world’s most tiny sport, and its recently held competition, the 2008 US RoboCup Open. We have covered nanobot nanosoccer in two posts recently: Public Invited to See Nanosoccer 2008 US RoboCup Open and Video of a Nanosoccer Nanobot.
    42535wi2 The Official Website of Nanobot Nanosoccer
    From a newly released statement by the NIST:

    Nanosoccer—the Lilliputian competition where computer-driven “nanobots” the size of dust mites challenge one another on fields no bigger than a grain of rice—will celebrate its first birthday this summer, and NIST is marking the anniversary with a new Web site at www.nist.gov/public_affairs/calmed/nanosoccer.html. Highlighting the site is a link to the recently produced video, “Bend It Like NIST: Tiny Soccer Players Pave Way for Microbots,” a 2-minute program that demonstrates how nanosoccer “road tests” agility, maneuverability, response to computer control and the ability to move objects—all skills that future miniaturized robot workers will need for tasks such as microsurgery within the human body or the manufacturing of atom-sized components for microscopic electronic devices.
    The soccer nanobots are operated by remote control under an optical microscope. They move in response to changing magnetic fields or electrical signals transmitted across the microchip arena. Although the bots are a few tens of micrometers to a few hundred micrometers long, they are considered “nanoscale” because their masses range from a few nanograms to a few hundred nanograms. They are manufactured from materials such as aluminum, nickel, gold, silicon and chromium.
    The new “NIST and Nanosoccer” Web site features summaries of the first two events in nanosoccer history: the July 2007 debut demonstration and competition at the international RoboCup in Atlanta, Ga., and the just-concluded demonstration at the RoboCup U.S. Open in Pittsburgh, Pa.
    NIST jointly organized these “Nanogram League” events with RoboCup, an international organization dedicated to fostering innovations and advances in artificial intelligence and intelligent robotics by using the game of soccer as a testing ground. NIST’s goal in coordinating competitions between the world’s smallest robots is to show the feasibility and accessibility of technologies for fabricating MicroElectroMechanical Systems (MEMS), tiny mechanical devices built onto semiconductor chips and measured in micrometers (millionth of a meter).
    Next up on the nanosoccer schedule is the first official Nanogram League competition for soccer nanobots at the July 2009 international RoboCup event in Austria.

    Website: NIST and Nanosoccer
    Press release: Learn About ‘NIST and Nanosoccer’ from New Web Site and Video…

    BioXcellDevice INVOcell Fertility Device Approved in EuropeBioXcell out of Beverly, MA has received approval in the EU to market its fertility assist device called INVOcell. The device, an incubator designed to hold a postfertilization oocyte(s), is placed into the maternal vaginal cavity. The idea is to replace the artificial in vitro fertilization (IVF) lab with a natural maternal environment to optimize early embryo development inside the INVOcell device.
    From the press release:

    According to Claude Ranoux, M.D., President and Chief Scientist of BioXcell, “INVOcell allows conception and embryo development to take place inside the woman’s body, making having a baby simpler and less expensive, while promoting more involvement by the woman. Our device, the INVOcell, and the INVO procedure, are less expensive and simpler to perform than conventional in vitro fertilization.”
    Dr. Ranoux added, “The INVO procedure uses a lower stimulation approach to produce eggs for fertilization. Eggs are combined with sperm in the INVOcell device and placed in the woman’s vaginal cavity where it remains for 3 days. This step eliminates the need for a complex IVF laboratory and allows the woman’s body to provide the nurturing environment in which conception and early embryo development take place.”

    Press release: BioXcell’s New INVOcell Receives CE Mark “Declaration of Conformity;” Allows Conception and Embryo Development to Take Place Inside the Woman’s Body
    Product page: INVOcell
    Abstract: INVO: a simple, low cost effective assisted reproductive technology Human Reproduction, doi:10.1093/humrep/den163
    Flashbacks: IVF Minus The Test Tube Goes On Trial

    Art

    4t35 Chickens Are Just Like You and Me, Except Theyre Chickens
    Someone out there in the Intrawebs has systematically photographed the prenatal formation of a chicken fetus grown outside the shell, and posted the photos online for all to ponder at how all of us were once…
    Link: The Birth of a Chicken.

    airplaneorcelery The Mind is a Difficult Thing to ReadCarnegie Mellon scientists have successfully performed the first rudimentary mind reading using functional magnetic resonance imaging, essentially identifying one of a number of words (“airplane” as opposed to “celery” in the image scan to the right) that subjects inside the machine were thinking about.
    From the Carnegie Mellon press release:

    In the study, nine subjects underwent fMRI scans while concentrating on 60 stimulus nouns – five words in each of 12 semantic categories including animals, body parts, buildings, clothing, insects, vehicles and vegetables.
    To construct their computational model, the researchers used machine learning techniques to analyze the nouns in a trillion-word text corpus that reflects typical English word usage. For each noun, they calculated how frequently it co-occurs in the text with each of 25 verbs associated with sensory-motor functions, including see, hear, listen, taste, smell, eat, push, drive and lift. Computational linguists routinely do this statistical analysis as a means of characterizing the use of words.
    These 25 verbs appear to be basic building blocks the brain uses for representing meaning, Mitchell said.
    By using this statistical information to analyze the fMRI activation patterns gathered for each of the 60 stimulus nouns, they were able to determine how each co-occurrence with one of the 25 verbs affected the activation of each voxel, or 3-D volume element, within the fMRI brain scans.
    To predict the fMRI activation pattern for any concrete noun within the text corpus, the computational model determines the noun’s co-occurrences within the text with the 25 verbs and builds an activation map based on how those co-occurrences affect each voxel.
    In tests, a separate computational model was trained for each of the nine research subjects using 58 of the 60 stimulus nouns and their associated activation patterns. The model was then used to predict the activation patterns for the remaining two nouns. For the nine participants, the model had a mean accuracy of 77 percent in matching the predicted activation patterns to the ones observed in the participants’ brains.
    The model proved capable of predicting activation patterns even in semantic areas for which it was untrained. In tests, the model was retrained with words from all but two of the 12 semantic categories from which the 60 words were drawn, and then tested with stimulus nouns from the omitted categories. If the categories of vehicles and vegetables were omitted, for instance, the model would be tested with words such as airplane and celery. In these cases, the mean accuracy of the model’s prediction dropped to 70 percent, but was still well above chance (50 percent).

    Press release: Carnegie Mellon Computer Model Reveals How Brain Represents Meaning
    (hat tip: Drudge Report)

    tamperinginscience 1.tiff Scientific Fauxtography Is More Common Than You Think
    The Chronicle of Higher Education profiles the use of image manipulation in peer reviewed journals, as Photoshop use is becoming common, and technology to detect its use is being developed.

    Ten to 20 of the articles accepted by The Journal of Clinical Investigation each year show some evidence of tampering, and about five to 10 of those papers warrant a thorough investigation, says Ms. Neill. (The journal publishes about 300 to 350 articles per year.)
    In the case of Ms. Roovers, editors notified the federal Office of Research Integrity, which polices government-financed science projects. The office concluded that the images had been improperly manipulated, as had images the researcher had produced for papers published in three other journals. That finding led two of those journals to retract papers that Ms. Roovers had co-authored, papers that had been cited by other researchers dozens of times.

    Much more info on the state of things from the Chronicle of Higher Education